Skip to main content

Read our report on six communities’ experiences with pandemic funding and programs, which provides valuable lessons learned to improve federal emergency response programs.

X
Skip to list of reports Filters

Date Range

Submitting Agency

Related Organizations

Any Recommendations

Any Open Recommendations

Reports

Search reports, investigative results, and agency plansShowing 111 - 120 of 180 results
Department of Labor OIG

Audit of ETA’s Oversight of UI Integrity for CARES Act Programs

Audit of ETA’s Oversight of UI Integrity for CARES Act Programs

Department of Labor OIG

COVID-19: Audit of States’ Information Technology Systems Capability in Processing Unemployment Insurance Claims

Department of Labor OIG

Audit of DOL and States’ Efforts to Detect and Recover Improper Payments for Programs Authorized by the Unemployment Insurance (UI) Provisions of CARES Act and Continued Assistance Act

The objective of this audit engagement is to determine if DOL ensured states had adequate controls to detect, prevent and recover UI improper payments under the Cares Act, and the Continued Assistance Act.

Department of Health & Human Services OIG

Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Department of Health & Human Services OIG

Yearend Review of Opioid Use in Medicare Part D in 2020

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020. 

Department of Labor OIG

COVID-19: Increased Worksite Complaints and Reduced OSHA Inspections Leave U.S. Workers' Safety at Increased Risk

Department of Labor OIG

Alert Memorandum: The Employment and Training Administration (ETA) Needs to Ensure State Workforce Agencies (SWA) Implement Effective Unemployment Insurance Program Fraud Controls for High Risk Areas

Department of Health & Human Services OIG

Awardee Challenges in Implementing COVID_19 Vaccination Program

CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.